Asymmetric hydrogenation, wherein a double bond is reduced using molecular hydrogen, is a popular way to add a stereocenter to a molecule. But asymmetric hydrogenation tends to break oximes’ N–O bonds ...
A multidisciplinary research team from the LKS Faculty of Medicine (HKUMed) and the Faculty of Engineering of the University of Hong Kong (HKU) has successfully developed an innovative screening ...
Janice Chambers is an author of a US patent owned by Mississippi State University on these oxime antidotes, and the oxime platform is licensed by Defender Pharmaceuticals. She has received funding on ...